Canadian-headquartered Tilray Brands, Inc. says it is expanding its medical cannabis product offerings for patients and related education for health professionals in Australia. Accessible via Australia’s Therapeutic Goods Administration (TGA) Special Access Scheme and Authorized Prescriber Scheme (where individual applications are approved), whole flower options including 1:1  (THC 10 CBD 10), mid-range (17), and high … Continue reading Tilray Expands Medical Cannabis Activity In Australia